Nullmax and Renesas Forge Strategic Partnership to Deliver Competitive ADAS Solutions for the Global Market

2025-02-26 IDOPRESS

SHANGHAI,Feb. 26,2025 -- On February 24,autonomous driving AI technology companyNullmax and global semiconductor solutions supplier Renesas Electronics officially signed a strategic partnership agreement in Shanghai. Zhe Sun,Head of Market Ecosystem at Nullmax,and Takeshi Fuse,Head of Business Development of High Performance Computing Product Group at Renesas,represented their respective companies at the signing ceremony.


Under this agreement,the two companies will engage in deep collaboration on Advanced Driver Assistance Systems (ADAS) applications,leveraging their respective strengths. By integrating Nullmax's efficient platform-based AI software algorithms with the exceptional performance of Renesas' R-Car V4 and R-Car X5 series chips,the partnership aims to develop reliable and user-friendly mass-production solutions for intelligent driving.

Zhe Sun,stated:

"We are pleased to establish this strategic partnership with Renesas. This collaboration will maximize Nullmax's expertise in autonomous driving AI algorithms while capitalizing on Renesas' robust chip performance. Together,we are committed to advancing breakthroughs and commercialization in autonomous driving technology. Through our close cooperation,we believe we can provide more efficient and reliable ADAS solutions for the global automotive industry,accelerating the widespread adoption and commercialization of smart driving technologies."

Takeshi Fuse,Head of Business Development of High Performance Computing Product Group at Renesas at Renesas,commented:

"We are very delighted to have Nullmax as a partner in AD & ADAS applications,Nullmax' proven perception solution enables fast implementation of AD & ADAS products built on Renesas SoCs,we will together bring more advance and more competitive products to support our customers make cars safer and smarter."

As a key player in the autonomous driving industry,Nullmax has been committed since its establishment in 2016 to develop full-scenario autonomous driving applications through advanced AI algorithms and proprietary platform-based technology,driving the intelligent transformation of mobility. This strategic collaboration between Nullmax and Renesas will provide global automakers and Tier 1 suppliers with more competitive autonomous driving solutions and services.

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

©copyright 2009-2020 Singapore Info Map